Clinical trial
Growth and Tolerance of Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas
NCT04006236 is registered in ClinicalTrials.gov with Abbott Nutrition as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Growth and Tolerance of Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas
- Lead sponsor
- Abbott Nutrition
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 5, 2019
- Completion date
- September 20, 2021
- Enrollment
- 245 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
infant development